25-HC also promotes cell migration and invasion in lung, gastric, and brain cancers by activating a G protein-coupled receptor or the Toll-like receptor 2 (TLR2)/NF-kB pathways and the LXR/interleukin-1B (IL-1B) signaling pathway56–58. Here, TLR2 is linked to brain cancer.